Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Board Changes

25 Feb 2015 07:02

RNS Number : 7836F
Phorm Corporation Limited
25 February 2015
Β 

25 FebruaryΒ 2015

Β 

PhormΒ CorporationΒ Limited

("Phorm"Β orΒ theΒ "Company")

Β 

BoardΒ Changes

Β 

PhormΒ (AIM:Β PHRM),Β aΒ leadingΒ internetΒ personalisationΒ technology company,Β announcesΒ thatΒ Mr Lex Fenwick is being appointed as a Non-Executive Director of the Company and that Lord Lamont has resigned.

Β 

BoardΒ Changes

Phorm is pleased to announce that Mr Lex Fenwick will be appointed as a Non-Executive Director of the Company on 1 March 2015. Mr Fenwick is former CEO of Dow Jones & Co. and former CEO of Bloomberg L.P. Mr Fenwick brings with him invaluable experience from international finance, data and media businesses. Phorm also announces that Lord Lamont has resigned from the Board with immediate effect.

Β 

Β 

KentΒ Ertugrul, Chairman andΒ CEOΒ ofΒ Phorm, commented:

"We are delighted to welcome Lex to the Phorm Board. As a world-class CEO his experience will be of huge value as the business moves into the next stage of its development, generating large scale commercial revenue in major markets. We would also like to take this opportunity to thank Lord Lamont for his advice and support over the last 6 years and wish him well for the future."

Β 

Lex FenwickΒ commented:

"I am extremely excited to be joining the board of Phorm at a pivotal stage in its development. I have been watching the business for a considerable period of time and I look forward to helping them scale and reach their commercial potential."

Β 

AdditionalΒ informationΒ onΒ MrΒ Lex Fenwick

TheΒ following additionalΒ information is providedΒ inΒ accordance withΒ paragraph (g)Β ofΒ Schedule TwoΒ toΒ theΒ AIM RulesΒ forΒ Companies:

Β 

Alexius ("Lex") John Benedict FenwickΒ (aged 55)

Β 

Current Directorships/Partnerships Β 

Past Directorships/Partnerships (last 5 years)

Selector Consultancy LLC

Dow Jones & Co.

Bloomberg L.P.

Bloomberg Inc.

Bloomberg Communications Inc.

Bloomberg SP Inc.

Bloomberg (GP) Finance LLC

Skillman Business Park LLC

Bloomberg T-Book Inc.

731 Funding LLC

Bloomberg Korea LLC

Bloomberg Finance Germany LLC

Bloomberg Ventures LLC

BLP Consulting Services Ltd.

Bloomberg New Zealand

Bloomberg Korea Ltd.

Bloomberg Data Services (India) Private Limited

BFM Financial Research Ltd.

Bloomberg Venezuela SRL

Bloomberg Bermuda Limited

Bloomberg Telecommunications Pte Ltd.

Bloomberg U.K. Limited

Bloomberg Value-Added Network Services South Africa (Proprietary) Limited

Bloomberg Chile Limitada

Β 

ThereΒ isΒ no otherΒ informationΒ thatΒ isΒ required toΒ beΒ disclosedΒ pursuantΒ toΒ paragraphΒ (g)Β ofΒ ScheduleΒ TwoΒ toΒ theΒ AIMΒ RulesΒ forΒ Companies.

Β 

Β 

-Ends-

ForΒ furtherΒ informationΒ pleaseΒ contact:Β PhormΒ CorporationΒ Limited

AndyΒ CroxsonΒ (analystsΒ andΒ investors) +44Β (0)Β 203Β 397Β 6001

Β 

UKΒ Investors

MirabaudΒ SecuritiesΒ LLPΒ (Broker) +44 (0) 207 321Β 2508

JasonΒ WoollardΒ PeterΒ Krens

Β 

StrandΒ HansonΒ LimitedΒ (NominatedΒ Adviser) +44 (0) 207 409Β 3494

JamesΒ HarrisΒ MatthewΒ ChandlerJamesΒ Dance

Β 

USΒ Investors

Lippert/HeilshornΒ and AssociatesΒ (InvestorΒ Relations) Β +1Β 212Β 838Β 3777

JohnΒ Heilshorn

Β 

AboutΒ Phorm

Phorm is a global personalisation technology company that makes content and advertising more relevant Β tothe consumer. Phorm'sΒ innovativeΒ platformΒ preservesΒ userΒ privacyΒ andΒ delivers aΒ moreΒ interestingΒ onlineΒ experience.

Β 

Phorm'sΒ Β industryΒ Β leading technology enablesΒ Β itsΒ Internet Service ProviderΒ ("ISP")Β partners to offer aΒ newΒ typeΒ ofΒ onlineadvertisingΒ platformΒ andΒ aΒ freeΒ consumerΒ internetΒ contentΒ feature,Β ensuringΒ moreΒ relevantΒ advertisementsΒ andΒ personalised content forΒ opted-in users.

Β 

Phorm'sΒ  advertising platform revolutionises current standardsΒ ofΒ onlineΒ privacy,Β fullyΒ protectingΒ theΒ identityΒ ofΒ consumers.Phorm's solution Β isΒ Β completelyΒ Β Β opt-in. OnlyΒ Β those usersΒ Β consenting toΒ Β theΒ Β service areΒ Β profiledΒ Β and onlyΒ Β ever onΒ anΒ anonymousΒ basis.

Β 

Phorm'sΒ partnersΒ includeΒ leading ISPs,Β Publishers, Advertising NetworksΒ and Advertisers.

Β 

Phorm,Β underΒ a Β predecessorΒ holding company, was admitted to the Β AIMΒ marketΒ of the LondonStockΒ ExchangeΒ inΒ 2004.

Β 

ForΒ moreΒ information, pleaseΒ visit:Β www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
BOATAMMTMBJTMPA
Date   Source Headline
9th Jun 20068:58 amPRNAdditional Listing
8th Jun 20067:00 amPRNDirector/PDMR Shareholding
5th Jun 200611:03 amPRNDirector/PDMR Shareholding
1st Jun 20064:40 pmPRNDirector/PDMR Shareholding
25th May 20067:00 amPRNTrading in and settlement of Common Shares
17th May 20067:00 amPRNAdditional Listing
27th Apr 200612:17 pmPRNDirector/PDMR Shareholding
20th Apr 20069:33 amPRNDirector/PDMR Shareholding
19th Apr 20067:00 amPRNFinal Results
6th Feb 20067:00 amPRNIssue of Equity
3rd Feb 20067:01 amPRNBlocklisting
3rd Feb 20067:00 amPRNBlocklisting
12th Jan 20067:00 amPRNTrading Update
28th Dec 20057:00 amPRNHolding(s) in Company
5th Dec 20057:00 amPRNDirectorate Change
11th Nov 20057:00 amPRNStatement re wireless ISP agreement
30th Sep 20057:31 amPRNInterim Results
8th Aug 20053:18 pmPRNResult of Stockholders Meeting
29th Jul 200510:20 amPRNAdditional Listing
22nd Jul 20059:22 amPRNPlacing to raise approx GBP1m
14th Jul 20056:00 amPRNAdditional Listing
23rd Jun 20052:46 pmPRNResult of AGM
23rd Jun 20058:55 amPRNAGM Statement
14th Jun 20053:37 pmPRNDirector Shareholding
4th May 20056:00 amPRNStatement re New Technology
21st Apr 20056:00 amPRNFinal Results
21st Apr 20056:00 amPRNDirectorate Change
4th Apr 200510:12 amPRNCorrection : Change of Adviser
4th Apr 20059:05 amPRNChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.